Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
481 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Nehal Adel Rayan Mohammed 2019
482 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2019
483 Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia 		Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2019
484 Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
 		Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2019
485 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis 		Department of Medical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2019
486 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
487 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2019
488 Pediatric Osteosarcoma of Extremities: a 15-year Experience from a Tertiary Care Cancer Center in Upper Egypt Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2019
489 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Clinical Pathology Asmaa Ahmed Mohamed ahmed 2019
490 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Department of Medical Oncology Dr. Abeer Elsayed Ali Ibrahim 2019